Notify me when Samuel D. Tweardy files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| CARA | TVARDI THERAPEUTICS, INC. | Common Stock, par value $0.001 per share | 3.4% | $7,365,343 | -$14,730,685 | 315,658 | -66.7% | Samuel D. Tweardy | 07 Jul 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|